The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Abstract
Authors
W.A. Malcolm C. Leteneux L. Claxton M. Taylor H. Rathi